Anthony Vendetti
Stock Analyst at Maxim Group
(3.81)
# 751
Out of 4,761 analysts
72
Total ratings
26.56%
Success rate
19.4%
Average return
Main Sectors:
Stocks Rated by Anthony Vendetti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAIN The Hain Celestial Group | Maintains: Buy | $15 → $10 | $4.18 | +139.23% | 7 | Feb 11, 2025 | |
| BHST BioHarvest Sciences | Initiates: Buy | $12 | $5.95 | +101.82% | 1 | Dec 18, 2024 | |
| ACON Aclarion | Downgrades: Hold | n/a | $5.11 | - | 2 | Dec 13, 2024 | |
| NXL Nexalin Technology | Downgrades: Hold | n/a | $2.87 | - | 2 | Dec 5, 2024 | |
| TNON Tenon Medical | Maintains: Buy | $22 → $8 | $1.39 | +475.54% | 1 | Nov 15, 2024 | |
| SRTS Sensus Healthcare | Maintains: Buy | $12 → $14 | $5.38 | +160.22% | 5 | Nov 15, 2024 | |
| NUTX Nutex Health | Maintains: Buy | $45 → $50 | $57.60 | -13.19% | 2 | Nov 12, 2024 | |
| HSDT Helius Medical Technologies | Downgrades: Hold | n/a | $0.54 | - | 2 | Oct 16, 2024 | |
| CELH Celsius Holdings | Maintains: Buy | $65 → $50 | $32.62 | +53.28% | 7 | Sep 5, 2024 | |
| DRMA Dermata Therapeutics | Maintains: Buy | $10 → $6 | $1.25 | +380.00% | 3 | Aug 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.83 | +622.89% | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.12 | - | 2 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.78 | +669.23% | 1 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $6.29 | +58.98% | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.77 | +182.49% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.45 | +566.67% | 1 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.35 | - | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2 | $5.71 | -64.97% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $1.75 | +7,042.86% | 1 | Apr 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $0.74 | +840.86% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.43 | - | 3 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $25 | $34.07 | -26.62% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.31 | - | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $140 | $0.22 | +64,120.18% | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $5 | $4.42 | +13.12% | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.58 | - | 2 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.41 | +112.77% | 1 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $19.47 | - | 2 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $160 | $0.16 | +101,810.83% | 3 | Nov 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | n/a | $40.68 | - | 3 | Jun 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $792 → $720 | $1.03 | +69,802.91% | 2 | Aug 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $10.11 | -50.54% | 1 | Jan 26, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.56 | - | 1 | May 31, 2016 |
The Hain Celestial Group
Feb 11, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $4.18
Upside: +139.23%
BioHarvest Sciences
Dec 18, 2024
Initiates: Buy
Price Target: $12
Current: $5.95
Upside: +101.82%
Aclarion
Dec 13, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.11
Upside: -
Nexalin Technology
Dec 5, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.87
Upside: -
Tenon Medical
Nov 15, 2024
Maintains: Buy
Price Target: $22 → $8
Current: $1.39
Upside: +475.54%
Sensus Healthcare
Nov 15, 2024
Maintains: Buy
Price Target: $12 → $14
Current: $5.38
Upside: +160.22%
Nutex Health
Nov 12, 2024
Maintains: Buy
Price Target: $45 → $50
Current: $57.60
Upside: -13.19%
Helius Medical Technologies
Oct 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.54
Upside: -
Celsius Holdings
Sep 5, 2024
Maintains: Buy
Price Target: $65 → $50
Current: $32.62
Upside: +53.28%
Dermata Therapeutics
Aug 21, 2024
Maintains: Buy
Price Target: $10 → $6
Current: $1.25
Upside: +380.00%
Jul 23, 2024
Initiates: Buy
Price Target: $6
Current: $0.83
Upside: +622.89%
Jul 17, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.12
Upside: -
Jan 30, 2024
Initiates: Buy
Price Target: $6
Current: $0.78
Upside: +669.23%
Dec 20, 2023
Initiates: Buy
Price Target: $10
Current: $6.29
Upside: +58.98%
Oct 5, 2023
Initiates: Buy
Price Target: $5
Current: $1.77
Upside: +182.49%
Oct 5, 2023
Initiates: Buy
Price Target: $3
Current: $0.45
Upside: +566.67%
Aug 11, 2023
Downgrades: Hold
Price Target: n/a
Current: $11.35
Upside: -
May 25, 2023
Initiates: Buy
Price Target: $2
Current: $5.71
Upside: -64.97%
Apr 20, 2023
Initiates: Buy
Price Target: $125
Current: $1.75
Upside: +7,042.86%
Mar 31, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $0.74
Upside: +840.86%
Mar 30, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.43
Upside: -
Mar 29, 2023
Maintains: Buy
Price Target: $15 → $25
Current: $34.07
Upside: -26.62%
Mar 28, 2023
Downgrades: Hold
Price Target: n/a
Current: $0.31
Upside: -
Mar 23, 2023
Maintains: Buy
Price Target: $240 → $140
Current: $0.22
Upside: +64,120.18%
Nov 15, 2022
Maintains: Buy
Price Target: $13 → $5
Current: $4.42
Upside: +13.12%
Nov 15, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.58
Upside: -
Oct 25, 2022
Initiates: Buy
Price Target: $3
Current: $1.41
Upside: +112.77%
Sep 21, 2022
Downgrades: Hold
Price Target: n/a
Current: $19.47
Upside: -
Nov 22, 2019
Upgrades: Buy
Price Target: $160
Current: $0.16
Upside: +101,810.83%
Jun 3, 2019
Upgrades: Hold
Price Target: n/a
Current: $40.68
Upside: -
Aug 16, 2018
Maintains: Buy
Price Target: $792 → $720
Current: $1.03
Upside: +69,802.91%
Jan 26, 2017
Upgrades: Buy
Price Target: $5
Current: $10.11
Upside: -50.54%
May 31, 2016
Downgrades: Hold
Price Target: n/a
Current: $0.56
Upside: -